Home » Books » Psychiatry » Pharmacologic Treatment of Schizophrenia, 3E 
Robert R. Conley, MD
Chief–Inpatient Research Program,
Professor of Psychiatry, University of Maryland
Deanna L. Kelly, PharmD, BCPP
Associate Professor of Psychiatry,
University of Maryland
Pharmacologic Treatment of Schizophrenia, 3E
Robert R. Conley, MDChief–Inpatient Research Program,
Professor of Psychiatry, University of Maryland
Deanna L. Kelly, PharmD, BCPPAssociate Professor of Psychiatry,
University of Maryland
Antipsychotics are reviewed, including efficacy, adverse effects, pharmacokinetics, mechanisms of action, and dosing. Topics covered include metabolic effects of antipsychotic drugs, mainagement of acute psychosis, long-acting antipsychotic drugs, and treatment-resistant schizophrenia. Pertinent clinical issues in management of this disease are reviewed.
| Availability: | In Stock | Add to Cart |
| Published In: | 2007 | |
| Length: | 288 pages | |
| ISBN: | 978-1-932610-22-2 | |
| Price: | $24.95 | View Book Index View Table of Contents |
